Skip to content

CLINICAL ASSESSMENT SCALES

Select atopic dermatitis clinical assessment scales

THE EASI COMPOSITE SCORING SYSTEM ASSESSES THE EXTENT AND SEVERITY OF LESIONS IN 4 DIFFERENT BODY REGIONS1

The EASI composite scoring system. Images highlighting areas of the body, extent, and severity of each region.

The above images are the property of and under license by the Waikato District Health Board.

For illustrative purposes only. Models are not clinical trial patients. Example severity strata based on literature.

 

Download EASI Scale

 

INVESTIGATOR’S GLOBAL ASSESSMENT SCALE FOR ATOPIC DERMATITIS: IGA2

Investigators global assessment scale for atopic dermatitis: IGA5

Example representation of IGA scoring. Not an actual patient.

 

Download IGA Scale

 

PRURITUS NUMERIC RATING SCALE (NRS)1

 

Download NRS Scale

 

PATIENT COUNSELING INFORMATION

Advise the patients and/or caregivers to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Graphic of nurse and patient

Administration Instructions

Instruct patients or caregivers:

  • to perform the first self-injection under the supervision and guidance of a qualified healthcare provider for proper training in subcutaneous injection technique

  • to inject the full dose of Adbry

  • to follow sharps disposal recommendations

Hypersensitivity

  • Advise patients to discontinue Adbry and to seek immediate medical attention if they experience any symptoms of systemic hypersensitivity reactions

Conjunctivitis and Keratitis

  • Advise patients to consult their healthcare provider if new-onset or worsening eye symptoms develop

Risk of Infection with Live Vaccines

  • Advise patients that Adbry may increase the risk of infection following administration of live vaccines and that vaccination with live vaccines is not recommended during Adbry treatment. Instruct patients to inform the healthcare provider that they are taking Adbry prior to a potential vaccination

References: 1. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI) assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-18. 2. Lesham YA, Hajar T, Hanifin JM, et al. What the eczema area and severity index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015; 172(5):1353-1357.